These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 8711587)

  • 21. [Natural history and prognostic factors of prostate cancer].
    Cussenot O
    Rev Prat; 1994 Mar; 44(5):580-5. PubMed ID: 8066393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sarcomatoid carcinoma of the prostate: a study of 42 cases.
    Hansel DE; Epstein JI
    Am J Surg Pathol; 2006 Oct; 30(10):1316-21. PubMed ID: 17001164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathologic evaluation of prostatic carcinoma: critical information for the oncologist.
    Epstein JI
    Oncology (Williston Park); 1996 Apr; 10(4):527-34; discussion 539, 541-3. PubMed ID: 8723283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular biology of prostatic intraepithelial neoplasia.
    Bostwick DG; Pacelli A; Lopez-Beltran A
    Prostate; 1996 Aug; 29(2):117-34. PubMed ID: 8700801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development, progression, and androgen-dependence of prostate tumors in probasin-large T antigen transgenic mice: a model for prostate cancer.
    Kasper S; Sheppard PC; Yan Y; Pettigrew N; Borowsky AD; Prins GS; Dodd JG; Duckworth ML; Matusik RJ
    Lab Invest; 1998 Mar; 78(3):319-33. PubMed ID: 9520945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for downregulation of calcium signaling proteins in advanced mouse adenocarcinoma.
    Ruddat VC; Whitman S; Klein RD; Fischer SM; Holman TR
    Prostate; 2005 Jul; 64(2):128-38. PubMed ID: 15666362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hormonal and molecular biological factors in pathogenesis of prostate cancer].
    Zezerov EG
    Vopr Onkol; 2001; 47(2):174-81. PubMed ID: 11383453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Steroid hormones stimulate human prostate cancer progression and metastasis.
    Ricke WA; Ishii K; Ricke EA; Simko J; Wang Y; Hayward SW; Cunha GR
    Int J Cancer; 2006 May; 118(9):2123-31. PubMed ID: 16331600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Steroid receptors in prostate cancer tissues and cells: pathophysiology, problems in methodology, clinical value and controversial questions.
    Pavone-Macaluso M; Carruba G; Castagnetta L
    Arch Esp Urol; 1994 Mar; 47(2):189-201. PubMed ID: 8002681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of the stromal microenvironment in carcinogenesis of the prostate.
    Cunha GR; Hayward SW; Wang YZ; Ricke WA
    Int J Cancer; 2003 Oct; 107(1):1-10. PubMed ID: 12925950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retinoic acid slows progression and promotes apoptosis of spontaneous prostate cancer.
    Huss WJ; Lai L; Barrios RJ; Hirschi KK; Greenberg NM
    Prostate; 2004 Oct; 61(2):142-52. PubMed ID: 15305337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of stroma in carcinogenesis of the prostate.
    Cunha GR; Hayward SW; Wang YZ
    Differentiation; 2002 Dec; 70(9-10):473-85. PubMed ID: 12492490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Malignant transformation of human prostatic epithelium is associated with the loss of androgen receptor immunoreactivity in the surrounding stroma.
    Olapade-Olaopa EO; MacKay EH; Taub NA; Sandhu DP; Terry TR; Habib FK
    Clin Cancer Res; 1999 Mar; 5(3):569-76. PubMed ID: 10100708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adenocarcinoma on needle prostatic biopsies: does reactive stroma predicts biochemical recurrence in patients following radical prostatectomy?
    Billis A; Meirelles L; Freitas LL; Polidoro AS; Fernandes HA; Padilha MM; Magna LA; Reis LO; Ferreira U
    Int Braz J Urol; 2013; 39(3):320-7. PubMed ID: 23849565
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prognosis significance of prostatic markers in patients with prostatic adenocarcinoma undergoing total hormonal blockade].
    Regueiro López JC; Ruiz Alvarez Cienfuegos F; Leva Vallejo M; Requena Tapia MJ; Merchan García JA; Prieto Castro R; Alvarez Kindelan J
    Actas Urol Esp; 1995 May; 19(5):357-62. PubMed ID: 8659288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model.
    Bonkhoff H; Remberger K
    Prostate; 1996 Feb; 28(2):98-106. PubMed ID: 8604398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Peptide growth factors in the prostate].
    Tatoud R; Desgrandchamps F; DeGeorges A; Thomas F
    Pathol Biol (Paris); 1993 Oct; 41(8):731-40. PubMed ID: 7507232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heat shock protein expression independently predicts clinical outcome in prostate cancer.
    Cornford PA; Dodson AR; Parsons KF; Desmond AD; Woolfenden A; Fordham M; Neoptolemos JP; Ke Y; Foster CS
    Cancer Res; 2000 Dec; 60(24):7099-105. PubMed ID: 11156417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prostatic neuroendocrine cells].
    Herrero M; Rodríguez A; Cejas H
    Rev Fac Cien Med Univ Nac Cordoba; 2002; 59(1):91-6. PubMed ID: 12934249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Morphological variants of prostatic endocrine diseases in old age].
    Derevianko IM; Batchaev SU; Shelegeda AS
    Urol Nefrol (Mosk); 1978; (6):22-6. PubMed ID: 82284
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.